Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
G A Bachmann
Dr G A Bachmann, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ, USA; email@example.com
randomised, placebo-controlled trial.
blinded (patients, healthcare providers, and data collectors).*
48 centres in the USA.
425 healthy postmenopausal women ⩾40 years of age (mean age 53 y, mean time since menopause 9 y) who had an average of ⩾7 (mean 10) moderate or severe hot flushes per day for ⩾1 week during screening. Exclusion criteria included abnormal Pap test result, abnormal vaginal bleeding, and a history of thrombophlebitis or thromboembolic disorder.
transdermal patches delivering 0.023 mg/day 17β-oestradiol (E2) plus 0.0075 mg/day levonorgestrel (low-dose group, n = 145), 0.014 mg/day E2 (micro-dose group, n = 147), or no E2 (placebo group, n = 133).
frequency and severity of hot …
Source of funding: Schering